Indeed, this is consistent with the notion that p53 wildtype glioma cells are more sensitive than p53 defective cells to TMZ-induced apoptosis [82], and with previous reports showing that TMZ administration was scarcely effective on apoptosis induction in GSCs [59]. The gene discussed is TP53; the disease is glioma.